Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > tetrasodium,(2S)-2-[[2-[(2S,3S)-7-carboxylato-3-(2-carboxylatoethyl)-17-ethenyl-12-ethyl-2,8,13,18-tetramethyl-2,3,23,24-tetrahydroporphyrin-5-yl]acetyl]amino]butanedioate

tetrasodium,(2S)-2-[[2-[(2S,3S)-7-carboxylato-3-(2-carboxylatoethyl)-17-ethenyl-12-ethyl-2,8,13,18-tetramethyl-2,3,23,24-tetrahydroporphyrin-5-yl]acetyl]amino]butanedioate

tetrasodium,(2S)-2-[[2-[(2S,3S)-7-carboxylato-3-(2-carboxylatoethyl)-17-ethenyl-12-ethyl-2,8,13,18-tetramethyl-2,3,23,24-tetrahydroporphyrin-5-yl]acetyl]amino]butanedioate structure

tetrasodium,(2S)-2-[[2-[(2S,3S)-7-carboxylato-3-(2-carboxylatoethyl)-17-ethenyl-12-ethyl-2,8,13,18-tetramethyl-2,3,23,24-tetrahydroporphyrin-5-yl]acetyl]amino]butanedioate 

structure
  • CAS No:

    220201-34-3

  • Formula:

    C38H37N5Na4O9

  • Chemical Name:

    tetrasodium,(2S)-2-[[2-[(2S,3S)-7-carboxylato-3-(2-carboxylatoethyl)-17-ethenyl-12-ethyl-2,8,13,18-tetramethyl-2,3,23,24-tetrahydroporphyrin-5-yl]acetyl]amino]butanedioate

  • Synonyms:

    Aptocine; Mono-L-aspartyl chlorin e6; Laserphyrin; Taporfin sodium; Talaporfin sodium; TalaporfinsodiuMsalt; mono-L-aspartin-chlorin e6; LS-11; talaporphin sodium; NPe6; mono-L-aspartyl chlorin e6 tetrasodium salt; (+)-tetrasodium (2S,3S)-18-carboxylato-20-[N-(S)-1,2-dicarboxylatoethyl]-carbamoylmethyl-13-ethyl-3,7,12,17-tetramethyl-8-vinylchlorin-2-propanoate; Laserphyrin (TN);Expand

  • Categories:

    Dyes and Pigments  >  Pigment

Description

Talaporfin Sodium is an agent consisting of chlorin e6, derived from chlorophyll, and L-aspartic acid with photosensitizing activity. After intratumoral activation by light emitting diodes, taporfin sodium forms an extended high energy conformational state that generates singlet oxygen, resulting in free radical-mediated cell death. (NCI04)

tetrasodium,(2S)-2-[[2-[(2S,3S)-7-carboxylato-3-(2-carboxylatoethyl)-17-ethenyl-12-ethyl-2,8,13,18-tetramethyl-2,3,23,24-tetrahydroporphyrin-5-yl]acetyl]amino]butanedioate Basic Attributes

799.68800

799.21820490

L63605PZ70

DTXSID70420519

C26675

Characteristics

245.92000

-2.26210

1175.5ºC at 760mmHg

664.7ºC

0mmHg at 25°C

Drug Information

Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)|Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)

laserphyrin

Computed Properties

Molecular Weight:799.7
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:8
Exact Mass:799.21820490
Monoisotopic Mass:799.21820490
Topological Polar Surface Area:247
Heavy Atom Count:56
Complexity:1340
Defined Atom Stereocenter Count:3
Covalently-Bonded Unit Count:5
Compound Is Canonicalized:Yes

Guide of tetrasodium,(2S)-2-[[2-[(2S,3S)-7-carboxylato-3-(2-carboxylatoethyl)-17-ethenyl-12-ethyl-2,8,13,18-tetramethyl-2,3,23,24-tetrahydroporphyrin-5-yl]acetyl]amino]butanedioate

Request for Quotation

Share

Scan the QR Code to Share

Complaint
Email:
Message:
Send Message